For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Vivus, Inc.

Calculating rank

USPTO Granted Patents = 45

% Expired Patents = 13.3

EPO Patents = 9

Trademarks = 20

Forward Citations = 1,457

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Virgil A Place (24 out of 50 patents)

Leland F Wilson (16 out of 18 patents)

Paul C Doherty, Jr (13 out of 16 patents)

4. Thomas Najarian (12 out of 12 patents)

5. Peter Y Tam (10 out of 10 patents)

6. William L Smith (8 out of 8 patents)

7. Neil Gesundheit (7 out of 14 patents)

8. Mark S Hanamoto (6 out of 9 patents)

9. Alfred P Spivack (5 out of 7 patents)

10. Sean R Bennett (5 out of 8 patents)

11. Randall G Berggren (4 out of 11 patents)

12. Robert M Gale (4 out of 73 patents)

13. Wesley Day (2 out of 2 patents)

14. Barbara Troupin (2 out of 2 patents)

15. Craig Peterson (2 out of 2 patents)

Core Competencies:

Type 2 Diabetes

Erectile Dysfunction

Weight Loss

Female Sexual Dysfunction

Obesity Treatment

Phosphodiesterase Inhibitors

Combination Therapy

Pulmonary Hypertension

Premature Ejaculation

Vasoactive Agents

Nitric Oxide

Dosage Forms

45 patents: Sort by Forward Citations

1. 10058532 - Methods of preventing progression to type 2 diabetes mellitus (2018-08-28),

2. 10028916 - Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and use (2018-07-24),

3. 9724327 - Methods of preventing progression to type 2 diabetes mellitus (2017-08-08),

4. 9011906 - Escalating dosing regimen for effecting weight loss and treating obesity (2015-04-21),

5. 9011905 - Low dose topiramate/phentermine composition and methods of use thereof (2015-04-21),

6. 8895058 - Low dose topiramate/phentermine composition and methods of use thereof (2014-11-25),

7. 8895057 - Escalating dosing regimen for effecting weight loss and treating obesity (2014-11-25),

8. 8802636 - Combination therapy for treatment of sleep apnea (2014-08-12),

9. 8580299 - Escalating dosing regimen for effecting weight loss and treating obesity (2013-11-12),

10. 8580298 - Low dose topiramate/phentermine composition and methods of use thereof (2013-11-12),

11. 8536138 - Treatment of pulmonary hypertension with carbonic anhydrase inhibitors (2013-09-17),

12. 8440671 - Compositions comprising a phoshodiesterase-5 inhibitor and their use in methods of treatment (2013-05-14),

13. 8071557 - Treatment of pulmonary hypertension with carbonic anhydrase inhibitors (2011-12-06),

14. 7674776 - Combination therapy for effecting weight loss and treating obesity (2010-03-09),

15. 7659256 - Combination therapy for effecting weight loss and treating obesity (2010-02-09),

Company Overview

Vivus, Inc., based in Mountain View, California, specializes in developing innovative therapies for various health conditions. The company focuses on areas such as type 2 diabetes prevention, weight loss therapy, and treatments for sleep apnea and pulmonary hypertension. Additionally, Vivus addresses sexual health issues, including female sexual dysfunction and erectile dysfunction, utilizing phosphodiesterase inhibitors in its therapeutic approaches. Through its commitment to advancing healthcare solutions, Vivus aims to improve patient outcomes across multiple domains.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

45 Patents

#76 in Mountain View, CA

#1,833 in California

#7,787 in US

#15,450 in the World

Mountain View, CA, United States of America

Vivus, Inc.

Forward Citations = 1,457

25 inventors:

Virgil A Place (24 out of 50 patents)

Leland F Wilson (16 out of 18 patents)

Paul C Doherty, Jr (13 out of 16 patents)

4. Thomas Najarian (12 out of 12 patents)

5. Peter Y Tam (10 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vivus, Inc.. Retrieved from https://idiyas.com/company/vivus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…